Updated results of a phase Ib/II study of carfilzomib (CFZ) in patients (pts) with relapsed malignancies

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2010
This article has no abstract
Epistemonikos ID: 28d76d0cf7c011a5d5755af468a28a43b3659dfa
First added on: Mar 01, 2025